Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Chan

Showing results (91-100 of 164) with videos related to

Pageof 17
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 21, 2018
Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selectionCharing C N Chong, Kit-Fai Lee, Cheuk-Man Chu, et al.
Investigational New Drugs|April 15, 2021
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinomaStephen L Chan, Paul N M Cheng, Angela M Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2020
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular CarcinomaRobin Kate Kelley, Tim Meyer, Lorenza Rimassa, et al.
Histopathology|July 6, 2016
Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapseAnthony W H Chan, Shuangni Yu, Yau-Hei Yu, et al.
BMC Cancer|January 6, 2017
Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life dataLeung Li, Frankie Kf Mo, Stephen L Chan, et al.
Clinical Chemistry|October 16, 2012
Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencingK C Allen Chan, Peiyong Jiang, Yama W L Zheng, et al.
Clinical Chemistry|August 31, 2021
Single Cell and Plasma RNA Sequencing for RNA Liquid Biopsy for Hepatocellular CarcinomaJoaquim S L Vong, Lu Ji, Macy M S Heung, et al.
Liver Cancer|October 30, 2023
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept StudyMasatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima, et al.
JCO Global Oncology|September 30, 2020
Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global WebinarsAbdul Rahman Jazieh, Stephen L Chan, Giuseppe Curigliano, et al.
Journal of Hepatology|June 11, 2025
Attenuation of the second peak of bimodal recurrence of HBV-related HCC after curative treatment in the antiviral eraLandon L Chan, Anthony W H Chan, Terry C F Yip, et al.
Pageof 17

Showing results (91-100 of 164) with videos related to

Sort By:
Pageof 17
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 21, 2018
Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selectionCharing C N Chong, Kit-Fai Lee, Cheuk-Man Chu, et al.
Investigational New Drugs|April 15, 2021
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinomaStephen L Chan, Paul N M Cheng, Angela M Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2020
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular CarcinomaRobin Kate Kelley, Tim Meyer, Lorenza Rimassa, et al.
Histopathology|July 6, 2016
Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapseAnthony W H Chan, Shuangni Yu, Yau-Hei Yu, et al.
BMC Cancer|January 6, 2017
Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life dataLeung Li, Frankie Kf Mo, Stephen L Chan, et al.
Clinical Chemistry|October 16, 2012
Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencingK C Allen Chan, Peiyong Jiang, Yama W L Zheng, et al.
Clinical Chemistry|August 31, 2021
Single Cell and Plasma RNA Sequencing for RNA Liquid Biopsy for Hepatocellular CarcinomaJoaquim S L Vong, Lu Ji, Macy M S Heung, et al.
Liver Cancer|October 30, 2023
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept StudyMasatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima, et al.
JCO Global Oncology|September 30, 2020
Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global WebinarsAbdul Rahman Jazieh, Stephen L Chan, Giuseppe Curigliano, et al.
Journal of Hepatology|June 11, 2025
Attenuation of the second peak of bimodal recurrence of HBV-related HCC after curative treatment in the antiviral eraLandon L Chan, Anthony W H Chan, Terry C F Yip, et al.
Pageof 17